Understanding how certain cells contribute to lung scarring in pulmonary fibrosis
Frontiers at the edge: Subpleural fibroblasts orchestrate pulmonary fibrosis progression
This study is looking into how certain cells in the lungs contribute to the worsening of idiopathic pulmonary fibrosis (IPF), with the goal of finding better ways to diagnose and treat this lung condition for patients like you.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11094718 on NIH RePORTER |
What this research studies
This research investigates idiopathic pulmonary fibrosis (IPF), a severe lung condition characterized by the formation of scar tissue. The study focuses on the role of specific fibroblast cells located at the edges of the lungs, which may drive the progression of fibrosis. Using advanced techniques like lineage tracing and single-cell sequencing, researchers aim to uncover the biological signals that initiate and exacerbate this disease. By identifying these mechanisms, the research seeks to improve early diagnosis and treatment options for patients with IPF.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with idiopathic pulmonary fibrosis or those at risk of developing this condition.
Not a fit: Patients with other forms of lung disease unrelated to pulmonary fibrosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for patients suffering from pulmonary fibrosis.
How similar studies have performed: Previous research has shown promising results in understanding the cellular mechanisms of fibrosis, suggesting that this approach could yield valuable insights.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Xu, Le — University of California, San Diego
- Study coordinator: Xu, Le
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.